Title : Cyclooxygenase-2 specific inhibitors in the treatment of dysmenorrhea.

Pub. Date : 2004 Apr

PMID : 15050982






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In vivo studies have found the specific COX-2 inhibitors rofecoxib (Vioxx) and valdecoxib (Bextra) effective in treatment of primary dysmenorrhea in women >or=18 years. rofecoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens
2 In vivo studies have found the specific COX-2 inhibitors rofecoxib (Vioxx) and valdecoxib (Bextra) effective in treatment of primary dysmenorrhea in women >or=18 years. rofecoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens